Essential role of B-helix calcium binding sites in annexin V-membrane binding.
Crystal structures of annexin V have shown up to 10 bound calcium ions in three different types of binding sites, but previous work concluded that only one of these sites accounted for nearly all of the membrane binding affinity of the molecule. In this study we mutated residues contributing to potential calcium binding sites in the AB and B helices in each of the four domains (eight sites in total) and in DE helices in the first, second, and third domains (three sites in total). We measured the affinity of each protein for phospholipid vesicles and cell membranes by quantitative calcium titration under low occupancy conditions (< 1% saturation of available membrane binding sites). Affinity was calculated from the midpoint and slope of the calcium titration curve and the concentration of membrane binding sites. The results showed that all four AB sites were essential for high affinity binding, as were three of the four B sites (in domains 1, 2, and 3); the DE site in the first domain made a slight contribution to affinity. Multisite mutants showed that each domain contributed additively and independently to binding affinity; in contrast, AB and B sites within the same domain were interdependent. The number of functionally important sites identified was consistent with the Hill coefficient observed in calcium titrations. This study shows an essential and previously unappreciated role for B-helix calcium binding sites in the membrane binding of annexins and indicates that all four domains of the molecule are required for maximum membrane binding affinity.
Jin
Ming
M
Department of Laboratory Medicine, University of Washington, Seattle, Washington 98195, USA.
Smith
Christina
C
Hsieh
Heng-Yu
HY
Gibson
Donald F
DF
Tait
Jonathan F
JF
D000595:Amino Acid Sequence; D017304:Annexin A5 / Q000737:chemistry* / Q000494:pharmacology; D001665:Binding Sites; D002118:Calcium / Q000737:chemistry* / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism*; D018360:Crystallography, X-Ray; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004926:Escherichia coli / Q000378:metabolism; D005452:Fluoresceins / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007477:Ions; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D011485:Protein Binding; D017434:Protein Structure, Tertiary
D017304:Annexin A5; D004791:Enzyme Inhibitors; D005452:Fluoresceins; D007477:Ions; C015296:5-iodoacetamidofluorescein; D002118:Calcium